Navigation Links
Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies

RESEARCH TRIANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews via COMTEX News Network) -- Adherex Technologies Inc. (TSX:AHX)(AMEX:ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, today announced that Dr. Antonella Perotti, MD, Istituto Nazionale dei Tumori Milano, SENDO Foundation, an investigator in Adherex's European Phase Ib/II study of single-agent ADH-1, will present data today from that study at the 5th International Symposium on Targeted Anticancer Therapies in Amsterdam, The Netherlands.

The data includes 30 patients who received an aggregate of over 200 doses (68 cycles) of ADH-1 given on a weekly schedule with doses ranging from 150 to 2400 mg/m2. ADH-1 was well tolerated at all doses tested for periods of up to eight months, displayed predictable pharmacokinetics, and demonstrated hints of anti-tumor activity in five patients with advanced, chemotherapy-resistant cancer. A maximum tolerated dose was not defined.

"This European data is consistent with our prior clinical experience, showing ADH-1 to be well tolerated over a broad dosage range with hints of anti-tumor activity in a variety of tumor types," said William P. Peters, MD, PhD, Chairman and CEO of Adherex. "Given the unexpected level of synergy of ADH-1 in combination with chemotherapy that we have reported from our preclinical studies, the clinical development of this drug continues fully on track. We expect to have results from the North American Phase II trial with single-agent ADH-1 as well as initial results from our ongoing Phase I combination studies with ADH-1 and chemotherapy available later this year."

In the European Phase Ib/II study, three of 19 patients (16%) with ovarian/gynecological tumors experienced evidence of anti-tumor activity, one with an unconfirmed partial response (previously reported) and two with prolonged stabilization of their disease, which were previously
'"/>




Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Malvern initiates European user group meetings for chemical imaging
7. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
8. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
9. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
10. Inspire Announces Presentations at Two European Scientific Conferences
11. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Post Your Comments:
(Date:5/23/2013)... 23, 2013  Net Medical Xpress Solutions, Inc., (OTC ... today the company has signed a letter of intent ... in Huntsville, AL . MedTel Solutions ... staffing and recruitment of telemedicine physicians. Consideration for the ... agreement, which is expected by June 30, 2013. ...
(Date:5/23/2013)... -- Israel Brain Technologies (IBT) has announced the ... 1 st International Brain Technology Conference, which ... in Tel Aviv , recently ranked as ... by the Wall Street Journal and the epicenter ... showcase the latest breakthroughs in neuroscience and brain technology and ...
(Date:5/23/2013)... 2013  Datameer announced today that Cardinal Health ... on their big data platform. Datameer gives Cardinal ... to quickly and easily visualize and understand data ... 19 company, Cardinal Health is one of the ... and medical products to more than 60,000 locations ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Cardinal Health Selects Datameer for Healthcare Data Discovery 2
... SNY ) announced today that it has submitted ... ) in an all-cash transaction valued at approximately $18.5 billion. ... Genzyme shareholders would receive $69 per Genzyme share in cash, ... $49.86 on July 1, 2010. Sanofi-aventis, offer also represents a ...
... Inc. Magazine/Inc.com selects online retail company PainReliever.com (Pain Relievers, ... in the United States. PainReliever.com is owned by Norris ... that a store from Norris E-Commerce Management has won ... was awarded as an Inc. 5000 recipient. ...
Cached Medicine Technology:Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 2Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 3Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 4Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 5Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 6Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 7Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme 8PainReliever.com Earns Inc. 5000 Award 2
(Date:5/23/2013)... Ill. (May 23, 2013) Aortic arch pulse wave ... independent predictor of disease of the vessels that supply ... published in the June issue the journal Radiology ... arch provides functional information about vessel compliance that may ... the road," said Kevin S. King, M.D., assistant professor ...
(Date:5/23/2013)... Elegance for a woman takes on so many different styles. ... can often be found in the mystery of her eyes. It ... through her eyes. It is also true that that her ... the elegance of a woman can be found in her precise ... any other time, utilize eyewear to not only compliment but to ...
(Date:5/23/2013)... Los Angeles, CA (PRWEB) May 23, 2013 ... showcasing the most innovative and stylish eco-friendly hybrids and electric ... savored than in Los Angeles, the symbolic green car capital. ... annual Green Car Tour ride and drive back to ... modern design event. , During the first two days ...
(Date:5/23/2013)... neuroblastoma a common tumor that forms in the nerve ... A study published by Cell Press in the May ... a new genomic approach to screen for compounds that ... differentiate, or convert from immature cells to more specialized ... a compound that causes neuroblastoma cells to differentiate, uncovering ...
(Date:5/23/2013)... Diabetes is one of the worst diseases ... when patients are unfortunate enough to become victims of ... Information Clearinghouse at http://goo.gl/QyhCz , about 60-70 percent ... neuropathy which further shrivels the nervous system and causes ... nerve damage affects the whole body instead of just ...
Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2
... April 2009, the US District Court for the District ... restraining order, barring Apotex (Apotex, Inc. and Apotex Corp.) ... until further order of the court. On 27 ... determine whether the injunction should be continued.On 30 March ...
... the highlights of the annual meeting of the American ... TV quiz shows. , Like a quiz show, Neurobowl ... subtracts points for wrong answers. The tougher the question, ... to diagnose perplexing neurological conditions, based on symptoms, video ...
... ANDOVER, Mass., April 16 JAZD Markets, the leader in ... announced that it has recently added SEO/SEM veteran Eric Melin ... team to optimize the directory verticals and report directly to ... SEO Guru in Eric Melin , JAZD is ...
... many people out of work, each day, thousands of new ... to this, FDP Inc. has assembled a directory website to ... With average waiting times of one to three years ... and take any job they can find. But, with fewer ...
... Calif., April 16 The California Dental ... deadline is rapidly approaching to have your kindergartener receive ... 2009-10 school year.The requirement has been in effect for ... common chronic childhood disease, it is essential that children ...
... MedInsights, Inc. , a leading provider of ... VIIAD,s award-winning Health Ticket technology ... to adopt VIIAD,s Health Ticket.The MedInsights Care Ticket, powered ... that goes beyond a traditional group health card and ...
Cached Medicine News:Health News:Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT RESPULES Patent Litigation 2Health News:What do neurologists do for entertainment? 2Health News:JAZD Adds Search Marketing & SEO Executive Eric Melin as VP, Traffic Generation Team 2Health News:Social Security Attorney Directory Helps to Speed SSDI Benefits 2Health News:California Dental Association Reminds Parents of Kindergarten Dental Check-Up Requirement 2Health News:National Managed Care Provider First to Workers' Compensation Market with Innovative Technology that Reduces Costs to Employers 2
The Clark Socket fits all American-made tables with standard 3/8"W x 1 1/8" H siderails. Fits round mounting posts up to 11/16" in diameter....
Inquire...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad) Wide angle of view...
Inquire...
Medicine Products: